Sumatriptan-naproxen migraine efficacy in allodynic patients: Early intervention

Headache

Volumn 52, Issue 1, 2012, Pages 133-139

  Landy, Stephen ^a   Hoagland, Rebecca ^b   Hoagland, Nancy A ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b Cota Enterprises ^*  (United States)

Author keywords

allodynia; headache; migraine; naproxen sodium; sumatriptan; triptan

Indexed keywords

NAPROXEN PLUS SUMATRIPTAN SUCCINATE;

ADULT; AGED; ALLODYNIA; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; HUMAN; MALE; MIGRAINE; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SENSITIZATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; EARLY INTERVENTION (EDUCATION); FEMALE; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAPROXEN; PROSPECTIVE STUDIES; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856241321     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01992.x     Document Type: Article

References (19)

1. Jakubowski M, Levy D, Goor-Aryeh I,. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of Cox1/Cox2 inhibitors. Headache. 2005; 45: 850-861. (Pubitemid 41045361)
2. Brandes JL, Kudrow D, Stark SR, et al,. Sumatriptan-naproxen for the acute treatment of migraine. JAMA. 2007; 297: 1443-1454.
3. Landy S, DeRossett SE, Rapoport A, et al,. Two double-blind, multicenter, randomized, placebo-controlled, single dose studies of sumatriptan/naproxen sodium in the acute treatment migraine: Function, productivity, and satisfaction outcomes. MedGenMed. 2007; 9: 53.
4. Burstein R, Collin B, Jakubowski M,. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol. 2004; 55: 19-26. (Pubitemid 38067357)
5. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
6. Ashkenazi A, Silberstein S, Jakubowski M, et al,. Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia. 2007; 27: 325-329. (Pubitemid 46434961)
7. Revicki DA, Kimel M, Beusterien K, et al,. Validation of the revised patient perception of migraine questionnaire: Measuring satisfaction with acute migraine treatment. Headache. 2006; 46: 240-252.
8. Burstein R, Jakubowski M,. Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization. Ann Neurol. 2004; 55: 27-36. (Pubitemid 38067358)
9. Burstein R, Jakubowski M, Levy D,. Naproxen suppresses sensitization in the central trigeminovascular neurons: Implication for migraine therapy (abstract). Neurology. 2006; 66 (Suppl. 2): A69.
10. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack: Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123: 1703-1709. (Pubitemid 30481193)
11. Landy SH, McGinnis JE, McDonald SA,. Clarification of developing and established clinical allodynia and pain-free outcomes. Headache. 2007; 47: 247-252.
12. Cady R, Martin V, Mauskop A, et al,. Symptoms of cutaneous sensitivity pre-treatment and post-treatment: Results form the rizatriptan TAME studies. Cephalalgia. 2007; 27: 1055-1060. (Pubitemid 47296031)
13. Lampl C, Huber G, Haas S, et al,. Difference in triptan effect in patients with migraine and early allodynia. Cephalalgia. 2008; 28: 1031-1038.
14. Schoenen J, De Klippel N, Giurgea S, et al,. Almotriptan and its combination with aceclofenac for migraine attacks: A study of efficacy and the influence of auto-evaluated brush allodynia. Cephalalgia. 2008; 28: 1095-1105.
15. Krymchantowski AV, Barbosa JS,. Rizatriptan combined with rofecoxib vs rizatriptan for the acute treatment of migraine: An open label pilot study. Cephalalgia. 2002; 22: 309-312. (Pubitemid 41701449)
16. Krymchantowski AV, Bigal ME,. Rizatriptan versus riszatriptan plus rofecoxib versus rizatriptan tolfenamic acid in the acute treatment of migraine. BMC Neurol. 2004; 4: 10.
17. Cady R, Martin V, Mauskop A, et al,. Efficacy of rizatriptan 10mg administered early in a migraine attack. Headache. 2006; 46: 914-924. (Pubitemid 43794743)
18. Mathew NT, Finlayson G, Smith TR, et al,. Early intervention with almotriptan: Results of the AEGIS trial (Axert early migraine intervention study). Headache. 2007; 47: 189-198.
19. Winner P, Landy S, Richardson M, et al,. Early intervention in migraine with sumatriptan tablets 50mg versus 100mg: A pooled analysis of data from six clinical trials. Clin Ther. 2005; 27: 1785-1794. (Pubitemid 41815229)